ProFound Therapeutics

ProFound Therapeutics is a biotechnology company dedicated to discovering and developing innovative medicines by exploring the expanded human proteome. Founded in 2020 as part of Flagship Pioneering, the company utilizes its proprietary ProFoundry™ Platform, which integrates advanced protein detection technologies, biological data, and artificial intelligence to identify and validate novel proteins with therapeutic potential. The ProFoundry™ Platform combines data from various biological layers, including the genome and proteome, supported by a vast database. This approach allows for rapid assessment of novel proteins as potential drug candidates. ProFound Therapeutics focuses on multiple disease areas, including cardiovascular disease, obesity, oncology, immune modulation, metabolic diseases, and rare diseases, often in collaboration with leading pharmaceutical companies like Novartis and Pfizer. These strategic partnerships enhance the company's capabilities in protein discovery and target validation, driving the development of new therapeutic candidates.